78 related articles for article (PubMed ID: 25540268)
1. An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.
Wressnigg N; van der Velden MV; Portsmouth D; Draxler W; O'Rourke M; Richmond P; Hall S; McBride WJ; Redfern A; Aaskov J; Barrett PN; Aichinger G
Clin Vaccine Immunol; 2015 Mar; 22(3):267-73. PubMed ID: 25540268
[TBL] [Abstract][Full Text] [Related]
2. Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice.
Neighbours LM; Long K; Whitmore AC; Heise MT
J Virol; 2012 Oct; 86(19):10675-85. PubMed ID: 22837203
[TBL] [Abstract][Full Text] [Related]
3. Potential Serological Misdiagnosis of Barmah Forest Virus and Ross River Virus Diseases as Chikungunya Virus Infections in Australia: Comparison of ELISA with Neutralization Assay Results.
Kizu J; Graham M; Liu W
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543750
[TBL] [Abstract][Full Text] [Related]
4. Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site.
Powell LA; Miller A; Fox JM; Kose N; Klose T; Kim AS; Bombardi R; Tennekoon RN; Dharshan de Silva A; Carnahan RH; Diamond MS; Rossmann MG; Kuhn RJ; Crowe JE
Cell Host Microbe; 2020 Nov; 28(5):699-711.e7. PubMed ID: 32783883
[TBL] [Abstract][Full Text] [Related]
5. First evidence of concurrent enzootic and endemic transmission of Ross River virus in the absence of marsupial reservoirs in Fiji.
Togami E; Gyawali N; Ong O; Kama M; Cao-Lormeau VM; Aubry M; Ko AI; Nilles EJ; Collins-Emerson JM; Devine GJ; Weinstein P; Lau CL
Int J Infect Dis; 2020 Jul; 96():94-96. PubMed ID: 32114197
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic patterns of Ross River virus disease in Queensland, Australia, 2001-2011.
Yu W; Mengersen K; Dale P; Mackenzie JS; Toloo GS; Wang X; Tong S
Am J Trop Med Hyg; 2014 Jul; 91(1):109-118. PubMed ID: 24799374
[TBL] [Abstract][Full Text] [Related]
7. Exposure dynamics of Ross River virus in horses - Horses as potential sentinels (a One Health approach).
Yuen NKY; Bielefeldt-Ohmann H; Coyle MP; Henning J
Epidemiol Infect; 2024 Apr; 152():e67. PubMed ID: 38606586
[TBL] [Abstract][Full Text] [Related]
8. Development of a candidate vaccine against Ross River virus infection.
Yu S; Aaskov JG
Vaccine; 1994 Sep; 12(12):1118-24. PubMed ID: 7998422
[TBL] [Abstract][Full Text] [Related]
9. Antigenicity and immunogenicity of chikungunya virus-like particles from mosquito cells.
Tsai SK; Hsu YL; Chiao DJ; Shu PY; Lin HT; Chang SF; Lin HC; Huang SH; Wang CH; Hsiung CC; Lin CC; Wu TY; Kuo SC
Appl Microbiol Biotechnol; 2023 Jan; 107(1):219-232. PubMed ID: 36434113
[TBL] [Abstract][Full Text] [Related]
10. A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses.
Schmidt C; Hastert FD; Gerbeth J; Beissert T; Sahin U; Perkovic M; Schnierle BS
Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146452
[TBL] [Abstract][Full Text] [Related]
11. Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.
Torres-Ruesta A; Chee RS; Ng LFP
Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33922370
[TBL] [Abstract][Full Text] [Related]
12. Ross River Virus Infection: A Cross-Disciplinary Review with a Veterinary Perspective.
Yuen KY; Bielefeldt-Ohmann H
Pathogens; 2021 Mar; 10(3):. PubMed ID: 33802851
[TBL] [Abstract][Full Text] [Related]
13. A Review:
Ogunlade ST; Meehan MT; Adekunle AI; Rojas DP; Adegboye OA; McBryde ES
Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33435566
[TBL] [Abstract][Full Text] [Related]
14. The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.
Prow NA; Liu L; McCarthy MK; Walters K; Kalkeri R; Geiger J; Koide F; Cooper TH; Eldi P; Nakayama E; Diener KR; Howley PM; Hayball JD; Morrison TE; Suhrbier A
NPJ Vaccines; 2020; 5(1):44. PubMed ID: 32550013
[TBL] [Abstract][Full Text] [Related]
15. Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models.
Nguyen W; Nakayama E; Yan K; Tang B; Le TT; Liu L; Cooper TH; Hayball JD; Faddy HM; Warrilow D; Allcock RJN; Hobson-Peters J; Hall RA; Rawle DJ; Lutzky VP; Young P; Oliveira NM; Hartel G; Howley PM; Prow NA; Suhrbier A
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32380760
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease.
Powell LA; Fox JM; Kose N; Kim AS; Majedi M; Bombardi R; Carnahan RH; Slaughter JC; Morrison TE; Diamond MS; Crowe JE
PLoS Pathog; 2020 May; 16(5):e1008517. PubMed ID: 32365139
[TBL] [Abstract][Full Text] [Related]
17. PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice.
Supramaniam A; Bielefeldt-Ohmann H; Rudd PA; Webster J; Ferro V; Herrero LJ
PLoS One; 2019; 14(6):e0217998. PubMed ID: 31170255
[TBL] [Abstract][Full Text] [Related]
18. Arthritogenic Alphaviruses: A Worldwide Emerging Threat?
Levi LI; Vignuzzi M
Microorganisms; 2019 May; 7(5):. PubMed ID: 31091828
[TBL] [Abstract][Full Text] [Related]
19. Genome Sequences of Three Ross River Virus Isolates Obtained from the Australian Defence Force.
Liu W; Kizu J; Le Grand L; Mitchell I; Gauci PJ; Gubala AJ
Microbiol Resour Announc; 2019 Apr; 8(14):. PubMed ID: 30948463
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
